tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Takeda Discontinues Cell Therapy Efforts to Refocus Investments
PremiumCompany AnnouncementsTakeda Discontinues Cell Therapy Efforts to Refocus Investments
21d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
21d ago
Bristol Myers, Takeda, Astex to contribute data for AI tool, Reuters says
Premium
The Fly
Bristol Myers, Takeda, Astex to contribute data for AI tool, Reuters says
21d ago
Harmony Biosciences price target lowered to $48 from $49 at Needham
PremiumThe FlyHarmony Biosciences price target lowered to $48 from $49 at Needham
1M ago
Alkermes price target raised to $35 from $34 at JPMorgan
Premium
The Fly
Alkermes price target raised to $35 from $34 at JPMorgan
1M ago
Promising Phase 3 Results for Takeda’s Oveporexton Boost Buy Rating
Premium
Ratings
Promising Phase 3 Results for Takeda’s Oveporexton Boost Buy Rating
1M ago
Takeda announces U.S. FDA approved the sBLA for VONVENDI
PremiumThe FlyTakeda announces U.S. FDA approved the sBLA for VONVENDI
1M ago
Novavax’s COVID-19 vaccine Nuvaxovid approved in Japan
Premium
The Fly
Novavax’s COVID-19 vaccine Nuvaxovid approved in Japan
2M ago
Here’s what Wall Street experts are saying about Salesforce ahead of earnings
Premium
The Fly
Here’s what Wall Street experts are saying about Salesforce ahead of earnings
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100